LEMAITRE VASCULAR, INC. Restructuring Costs
LEMAITRE VASCULAR, INC. (LMAT) reported Restructuring Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. restructuring costs for the quarter ending 2024-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. restructuring costs for the quarter ending 2024-09-30 was $0.00.
- LEMAITRE VASCULAR, INC. restructuring costs for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. restructuring costs for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. restructuring costs for fiscal 2025 was $0.00.
- LEMAITRE VASCULAR, INC. restructuring costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. restructuring costs for fiscal 2023 was $485.00K, a 84.35% decline from fiscal 2022.
- LEMAITRE VASCULAR, INC. restructuring costs for fiscal 2022 was $3.10M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month | Restructuring Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $180.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $180.00K derived: sum of 3 quarters · filed 2026-02-26 | $485.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $180.00K derived: sum of 2 quarters · filed 2024-11-08 | $485.00K 10-Q · filed 2024-11-08 | $478.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-06-30 | $180.00K 10-Q · filed 2024-08-08 | $485.00K 10-Q · filed 2024-08-08 | $478.00K derived: sum of 3 quarters · filed 2026-02-26 | $478.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-03-31 | $305.00K 10-Q · filed 2024-05-10 | $298.00K derived: sum of 2 quarters · filed 2026-02-26 | $298.00K derived: sum of 3 quarters · filed 2026-02-26 | $3.40M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2022-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$7.00K derived: sum of 2 quarters · filed 2026-02-26 | $3.10M derived: sum of 3 quarters · filed 2026-02-26 | $3.10M 10-K · filed 2026-02-26 | $3.11M 10-K · filed 2023-03-01 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $3.11M derived: sum of 2 quarters · filed 2023-11-07 | $3.11M 10-Q · filed 2023-11-07 | $3.11M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $3.11M 10-Q · filed 2023-08-08 | $3.11M 10-Q · filed 2023-08-08 | $3.11M derived: sum of 3 quarters · filed 2024-02-29 | $3.11M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | ||||
| 2011-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $506.00K derived: sum of 2 quarters · filed 2013-03-27 | $1.16M derived: sum of 3 quarters · filed 2013-03-27 | $2.16M 10-K · filed 2013-03-27 | |
| 2011-09-30 | $394.00K 10-Q · filed 2012-11-09 | $1.04M derived: sum of 2 quarters · filed 2012-11-09 | $2.05M 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | $650.00K 10-Q · filed 2012-08-10 | $1.66M 10-Q · filed 2012-08-10 | |||
| 2010-12-31 | $1.82M 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |